Related references
Note: Only part of the references are listed.Potential Role of Carbon Nanomaterials in the Treatment of Malignant Brain Gliomas
Maria Caffo et al.
CANCERS (2023)
Novel amino analogs of the trimethoxyphenyl ring in potent colchicine site ligands improve solubility by the masked polar group incorporation (MPGI) strategy
Myriam Gonzalez et al.
BIOORGANIC CHEMISTRY (2023)
Temozolomide Resistance in Glioblastoma by NRF2: Protecting the Evil
Karoline Almeida Lima et al.
BIOMEDICINES (2023)
Tumor Microenvironment and Glioblastoma Cell Interplay as Promoters of Therapeutic Resistance
Edoardo Agosti et al.
BIOLOGY-BASEL (2023)
An update on the recent advances and discovery of novel tubulin colchicine binding inhibitors
Haoxiang Weng et al.
FUTURE MEDICINAL CHEMISTRY (2023)
Indole derivatives as tubulin polymerization inhibitors for the development of promising anticancer agents
Yu Hong et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2022)
Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Recent Trends in Tubulin-Binding Combretastatin A-4 Analogs for Anticancer Drug Development
Suresh Paidakula et al.
CURRENT MEDICINAL CHEMISTRY (2022)
Molecular interactions at the colchicine binding site in tubulin: An X-ray crystallography perspective
Jiaxing Wang et al.
DRUG DISCOVERY TODAY (2022)
A novel tubulin inhibitor, 6h, suppresses tumor-associated angiogenesis and shows potent antitumor activity against non-small cell lung cancers
Zi Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2022)
Emerging therapies for glioblastoma: current state and future directions
Liang Rong et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)
Natural Products/Bioactive Compounds as a Source of Anticancer Drugs
Syeda Tasmia Asma et al.
CANCERS (2022)
Recent advances in combretastatin A-4 codrugs for cancer therapy
Kerong Guo et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
Methylsulfanylpyridine based diheteroaryl isocombretastatin analogs as potent anti-proliferative agents
Raquel Alvarez et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Synthesis, self-assembly and anticancer drug encapsulation and delivery properties of cyclodextrin-based giant amphiphiles
Laura Gallego-Yerga et al.
CARBOHYDRATE POLYMERS (2021)
Anticancer properties of indole derivatives as IsoCombretastatin A-4 analogues
Shannon Pecnard et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Cytoskeletal proteins as glioblastoma biomarkers and targets for therapy: A systematic review
Alja Zottel et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2021)
Therapeutic strategies to overcome taxane resistance in cancer
Tuyelee Das et al.
DRUG RESISTANCE UPDATES (2021)
Characterization of Microtubule Destabilizing Drugs: A Quantitative Cell-Based Assay That Bridges the Gap between Tubulin Based- and Cytotoxicity Assays
Marie-Catherine Laisne et al.
CANCERS (2021)
New diarylsulfonamide inhibitors of Leishmania infantum amastigotes
Myriam Gonzalez et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2021)
New indolesulfonamide derivatives targeting the colchicine site of tubulin: synthesis, anti-tumour activity, structure-activity relationships, and molecular modelling
Alba Vicente-Blazquez et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2021)
Application of ensemble pharmacophore-based virtual screening to the discovery of novel antimitotic tubulin inhibitors
Laura Gallego-Yerga et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)
Methoxy and bromo scans on N-(5-methoxyphenyl) methoxybenzenesulphonamides reveal potent cytotoxic compounds, especially against the human breast adenocarcinoma MCF7 cell line
Myriam Gonzalez et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2021)
Design, synthesis and biological evaluation of 1-Aryl-5-(4-arylpiperazine-1-carbonyl)-1H-tetrazols as novel microtubule destabilizers
Chao Wang et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2021)
LigRMSD: a web server for automatic structure matching and RMSD calculations among identical and similar compounds in protein-ligand docking
Jose Luis Velazquez-Libera et al.
BIOINFORMATICS (2020)
Developments of isoCombretastatin A-4 derivatives as highly cytotoxic agents
Abdallah Hamze et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Potent colchicine-site ligands with improved intrinsic solubility by replacement of the 3,4,5-trimethoxyphenyl ring with a 2-methylsulfanyl-6-methoxypyridine ring
Raquel Alvarez et al.
BIOORGANIC CHEMISTRY (2020)
Tubulin inhibitors: Discovery of a new scaffold targeting extra-binding residues within the colchicine site through anchoring substituents properly adapted to their pocket by a semi-flexible linker
Raed M. Maklad et al.
BIOORGANIC CHEMISTRY (2020)
Nanoparticle-mediated therapeutic compounds delivery to glioblastoma
L. Gallego et al.
EXPERT OPINION ON DRUG DELIVERY (2020)
Anti-tubulin agents of natural origin: Targeting taxol, vinca, and colchicine binding domains
Fatima Naaz et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Targeting Tubulin-colchicine Site for Cancer Therapy: Inhibitors, Antibody-Drug Conjugates and Degradation Agents
Yongtao Duan et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2019)
The Masked Polar Group Incorporation (MPGI) Strategy in Drug Design: Effects of Nitrogen Substitutions on Combretastatin and Isocombretastatin Tubulin Inhibitors
Myriam Gonzalez et al.
MOLECULES (2019)
A novel tetrazole analogue of resveratrol is a potent anticancer agent
Shobanbabu Bommagani et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Vinca alkaloids and analogues as anti-cancer agents: Looking back, peering ahead
Emanuela Martino et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Recent advances in microtubule-stabilizing agents
Ya-Nan Cao et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Substitution at the indole 3 position yields highly potent indolecombretastatins against human tumor cells
Raquel Alvarez et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
JADOPPT: java based AutoDock preparing and processing tool
Carlos Garcia-Perez et al.
BIOINFORMATICS (2017)
Docetaxel-Loaded Nanoparticles Assembled from β-Cyclodextrin/Calixarene Giant Surfactants: Physicochemical Properties and Cytotoxic Effect in Prostate Cancer and Glioblastoma Cells
Laura Gallego-Yerga et al.
FRONTIERS IN PHARMACOLOGY (2017)
The Effect of Verapamil, a P-Glycoprotein Inhibitor, on the Pharmacokinetics of Peficitinib, an Orally Administered, Once-Daily JAK Inhibitor
Tong Zhu et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2017)
Synthesis and biological evaluation of cis-restricted triazole/tetrazole mimics of combretastatin-benzothiazole hybrids as tubulin polymerization inhibitors and apoptosis inducers
A. V. Subba Rao et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Taxane anticancer agents: a patent perspective
Iwao Ojima et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2016)
Pyridine Based Antitumour Compounds Acting at the Colchicine Site
R. Alvarez et al.
CURRENT MEDICINAL CHEMISTRY (2016)
Blocking Blood Flow to Solid Tumors by Destabilizing Tubulin: An Approach to Targeting Tumor Growth
Maria Jesus Perez-Perez et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Computational protein-ligand docking and virtual drug screening with the AutoDock suite
Stefano Forli et al.
NATURE PROTOCOLS (2016)
Colchicine: Old and New
Anastasia Slobodnick et al.
AMERICAN JOURNAL OF MEDICINE (2015)
New Ligands of the Tubulin Colchicine Site Based on X-Ray Structures
Raquel Alvarez et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2014)
Fosbretabulin for the treatment of anaplastic thyroid cancer
Roberta Granata et al.
FUTURE ONCOLOGY (2014)
The Binding Sites of Microtubule-Stabilizing Agents
Jessica J. Field et al.
CHEMISTRY & BIOLOGY (2013)
Endowing Indole-Based Tubulin Inhibitors with an Anchor for Derivatization: Highly Potent 3-Substituted Indolephenstatins and Indoleisocombretastatins
Raquel Alvarez et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
O6-methylguanine DNA methyltransferase as a promising target for the treatment of temozolomide-resistant gliomas
C-H Fan et al.
CELL DEATH & DISEASE (2013)
Cancer-Specific Requirement for BUB1B/BUBR1 in Human Brain Tumor Isolates and Genetically Transformed Cells
Yu Ding et al.
CANCER DISCOVERY (2013)
Targeting βIII-Tubulin in Glioblastoma Multiforme: From Cell Biology and Histopathology to Cancer Therapeutics
Christos D. Katsetos et al.
Anti-Cancer Agents in Medicinal Chemistry (2012)
The Tubulin Colchicine Domain: a Molecular Modeling Perspective
Alberto Massarotti et al.
CHEMMEDCHEM (2012)
Synthesis and Evaluation of 1,5-Disubstituted Tetrazoles as Rigid Analogues of Combretastatin A-4 with Potent Antiproliferative and Antitumor Activity
Romeo Romagnoli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
The ABC of the Blood-Brain Barrier - Regulation of Drug Efflux Pumps
Anne Mahringer et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
Drugs That Target Dynamic Microtubules: A New Molecular Perspective
Richard A. Stanton et al.
MEDICINAL RESEARCH REVIEWS (2011)
Microtubule-binding agents: a dynamic field of cancer therapeutics
Charles Dumontet et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Microtubules and resistance to tubulin-binding agents
Maria Kavallaris
NATURE REVIEWS CANCER (2010)
ABT-751, a novel tubulin-binding agent, decreases tumor perfusion and disrupts tumor vasculature
Yanping Luo et al.
ANTI-CANCER DRUGS (2009)
Isocombretastatins A: 1,1-Diarylethenes as potent inhibitors of tubulin polymerization and cytotoxic compounds
Raquel Alvarez et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Microtubule dynamics as a target in oncology
April L. Risinger et al.
CANCER TREATMENT REVIEWS (2009)
Empirical Scoring Functions for Advanced Protein-Ligand Docking with PLANTS
Oliver Korb et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2009)
Isocombretastatins A versus Combretastatins A: The Forgotten isoCA-4 Isomer as a Highly Promising Cytotoxic and Antitubulin Agent
Samir Messaoudi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Microtubules as a target for anticancer drugs
MA Jordan et al.
NATURE REVIEWS CANCER (2004)
UCSF chimera - A visualization system for exploratory research and analysis
EF Pettersen et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
Targeting tumour vasculature: the development of combretastatin A4
Jeremy Griggs et al.
LANCET ONCOLOGY (2001)
Share Paper
